Hillstream Biopharma Stock Total Debt
| HILSDelisted Stock | USD 0.39 0.01 2.50% |
Hillstream Biopharma fundamentals help investors to digest information that contributes to Hillstream Biopharma's financial success or failures. It also enables traders to predict the movement of Hillstream Stock. The fundamental analysis module provides a way to measure Hillstream Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hillstream Biopharma stock.
Hillstream |
Hillstream Biopharma Company Total Debt Analysis
Hillstream Biopharma's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Hillstream Biopharma Total Debt | 772.9 K |
Most of Hillstream Biopharma's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hillstream Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Hillstream Biopharma has a Total Debt of 772.9 K. This is 99.97% lower than that of the Biotechnology sector and 99.76% lower than that of the Health Care industry. The total debt for all United States stocks is 99.99% higher than that of the company.
Hillstream Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hillstream Biopharma's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics of similar companies.Hillstream Biopharma is currently under evaluation in total debt category among its peers.
Hillstream Fundamentals
| Return On Equity | -1.47 | |||
| Return On Asset | -0.78 | |||
| Current Valuation | 496.66 K | |||
| Shares Outstanding | 17.53 M | |||
| Shares Owned By Insiders | 38.90 % | |||
| Shares Owned By Institutions | 0.80 % | |||
| Number Of Shares Shorted | 52.74 K | |||
| Price To Book | 0.88 X | |||
| EBITDA | (6.88 M) | |||
| Net Income | (8.47 M) | |||
| Cash And Equivalents | 9.48 M | |||
| Cash Per Share | 0.82 X | |||
| Total Debt | 772.9 K | |||
| Current Ratio | 13.13 X | |||
| Book Value Per Share | 0.18 X | |||
| Cash Flow From Operations | (6.56 M) | |||
| Short Ratio | 0.20 X | |||
| Earnings Per Share | (0.76) X | |||
| Target Price | 4.0 | |||
| Market Capitalization | 4.23 M | |||
| Total Asset | 6.69 M | |||
| Retained Earnings | (15.38 M) | |||
| Working Capital | 5.54 M | |||
| Z Score | -2.34 | |||
| Net Asset | 6.69 M |
About Hillstream Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hillstream Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hillstream Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hillstream Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |